Takaji Ryo, Kiyosue Hiro, Maruno Miyuki, Hongo Norio, Shimada Ryuichi, Ide Satomi, Tokuyama Kohei, Okamoto Mamiko, Kawano Yasushi, Asayama Yoshiki
Departments of Radiology, Oita University Faculty of Medicine, Yufu City, Oita, 879-5593, Japan.
Department of Obstetrics and Gynecology, Oita University Faculty of Medicine, Yufu, Oita, 879-5593, Japan.
CVIR Endovasc. 2021 Nov 2;4(1):77. doi: 10.1186/s42155-021-00265-z.
To clarify characteristic angiographic features and clinical efficacy of selective transarterial embolization (TAE) of retained placenta with abnormal vaginal bleeding.
The study cohort comprised 22 patients (mean age, 33.5 years; range, 22-24 years) who underwent selective TAE for retained placenta with abnormal bleeding between January 2018 and December 2020 at our institution. Angiographic images were reviewed by two certified radiologists with consensus. Medical records were reviewed to evaluate the efficacy of TAE. Angiographic features of retained placenta, technical success (disappearance of abnormal findings on angiography), complications, clinical outcomes (hemostatic effects and recurrent bleeding) were evaluated.
Pelvic angiography showed a dilated vascular channel mimicking arteriovenous fistulas or an aneurysm contiguous with dilated uterine arteries in the mid-arterial-capillary phase in 20 patients; it showed contrast brush in the remaining two patients. TAE technical success was achieved in all patients. No major complications were observed in any patients. Fifteen patients were followed up with expectant management after TAE; all but one patient showed no re-bleeding during the follow-up period (mean follow-up interval, 3.4 months; range, 1-17 months). One patient showed minor rebleeding, which resolved spontaneously. Seven patients underwent scheduled hysteroscopic resection within 1 week after TAE, and no excessive bleeding was observed during or after the surgical procedure in all seven patients.
The characteristic angiographic feature of retained placenta is "dilated vascular channel that mimic low flow AVM." TAE is a safe and effective treatment to manage retained placenta with abnormal bleeding.
阐明阴道异常出血的胎盘植入患者选择性经动脉栓塞术(TAE)的血管造影特征及临床疗效。
本研究队列包括22例患者(平均年龄33.5岁;范围22 - 44岁),于2018年1月至2020年12月在我院接受TAE治疗阴道异常出血的胎盘植入。由两名认证放射科医生共同回顾血管造影图像。查阅病历以评估TAE的疗效。评估胎盘植入的血管造影特征、技术成功率(血管造影异常表现消失)、并发症、临床结局(止血效果和复发出血)。
盆腔血管造影显示,20例患者在动脉-毛细血管中期出现类似动静脉瘘的扩张血管通道或与扩张子宫动脉相邻的动脉瘤;其余2例患者显示造影剂涂抹。所有患者均取得TAE技术成功。所有患者均未观察到严重并发症。15例患者TAE后采用期待治疗随访;除1例患者外,所有患者在随访期间均未再次出血(平均随访间隔3.4个月;范围1 - 17个月)。1例患者出现轻微复发出血,自行缓解。7例患者在TAE后1周内接受了计划性宫腔镜切除术,所有7例患者在手术期间及术后均未观察到出血过多。
胎盘植入的特征性血管造影表现为“类似低流量动静脉畸形的扩张血管通道”。TAE是治疗阴道异常出血胎盘植入的一种安全有效的方法。